ArticleQuantitative imaging in medicine and surgery2025
Imaging analysis of adjacent segment disease combined with retrolisthesis after posterior lumbar interbody fusion: a preliminary cross-sectional comparative study.
Article in Quantitative imaging in medicine and surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Adjacent segment disease (ASD) combined with retrolisthesis of the adjacent vertebrae is a common radiological phenomenon. However, its characteristics remain unclarified. This study aimed to investigate the epidemiology of ASD with retrolisthesis, preliminarily analyze its radiological features, and identify its risk factors. Methods: The diagnostic criteria for symptomatic ASD were defined as the recurrence of radiating lower limb pain after the initial surgery and radiological evidence of degeneration at the adjacent fused segment indicating revision surgery. Retrolisthesis in ASD was defined as a ≥3 mm posterior slip of the superior vertebra of the affected segment on a lateral X-ray, no-slip status as the absence of anterior or posterior slippage of the superior vertebra in the affected segments, and anterolisthesis as a ≥3 mm anterior slip of the superior vertebral body. All patients who underwent surgical treatment for symptomatic ASD between November 2020 and July 2024 at the Third Hospital of Hebei Medical University with an initial operation of posterior lumbar interbody fusion (PLIF) were analyzed. Patients were divided into a retrolisthesis group (group A), a no-slip group (group B), and a anterolisthesis group (group C). The demographic information and imaging data were compared between the groups. In addition, we collected preoperative imaging data from the initial surgery for patients in each group and performed a comparative analysis. Results: A total of 165 patients were included in this study, with 102 (61.8%) being included in group A (retrolisthesis group), 20 (12.1%) in group B (no-slip group), and 43 (26%) in group C (anterolisthesis group). Group A, as compared to group B, had significantly lower disc height (0.76±0.25 Conclusions: ASD combined with retrolisthesis was the most common of the three patterns of ASD, and patients with this condition had severe degeneration of discs and facet joints and significant atrophy of the MF. Reduced disc height, severe disc degeneration, and atrophy of the MF were the risk factors for ASD combined with retrolisthesis. In summary, we hypothesize that early lumbar muscle-strengthening exercises may reduce ASD risk in patients with adjacent vertebral retrolisthesis detected on postoperative follow-up radiographs after lumbar fusion. This should be validated in controlled, prospective studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.